Exact Mass: 305.2022

Exact Mass Matches: 305.2022

Found 311 metabolites which its exact mass value is equals to given mass value 305.2022, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Capsaicin

(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide

C18H27NO3 (305.1991)


Capsaicin is a capsaicinoid. It has a role as a non-narcotic analgesic, a voltage-gated sodium channel blocker and a TRPV1 agonist. Capsaicin is most often used as a topical analgesic and exists in many formulations of cream, liquid, and patch preparations of various strengths; however, it may also be found in some dietary supplements. Capsaicin is a naturally-occurring botanical irritant in chili peppers, synthetically derived for pharmaceutical formulations. The most recent capsaicin FDA approval was Qutenza, an 8\\\\\\% capsaicin patch dermal-delivery system, indicated for neuropathic pain associated with post-herpetic neuralgia. Capsaicin is a natural product found in Capsicum pubescens, Capsicum, and Capsicum annuum with data available. Capsaicin is a chili pepper extract with analgesic properties. Capsaicin is a neuropeptide releasing agent selective for primary sensory peripheral neurons. Used topically, capsaicin aids in controlling peripheral nerve pain. This agent has been used experimentally to manipulate substance P and other tachykinins. In addition, capsaicin may be useful in controlling chemotherapy- and radiotherapy-induced mucositis. Capsaicin is identified as the primary pungent principle in Capsicum fruits. Hot chili peppers that belong to the plant genus Capsicum (family Solanaceae) are among the most heavily consumed spices throughout the world. The capsaicin content of green and red peppers ranges from 0.1 to 1\\\\\\%. Capsaicin evokes numerous biological effects and thus has been the target of extensive., investigations since its initial identification in 1919. One of the most recognized physiological properties of capsaicin is its selective effects on the peripheral part of the sensory nervous system, particularly on the primary afferent neurons. The compound is known to deplete the neurotransmitter of painful impulses known as substance P from the sensory nerve terminals, which provides a rationale for its use as a versatile experimental tool for studying pain mechanisms and also for pharmacotherapy to treat some peripheral painful states, such as rheumatoid arthritis, post-herpetic neuralgia, post-mastectomy pain syndrome and diabetic neuropathy. Considering the frequent consumption of capsaicin as a food additive and its current therapeutic application, correct assessment of any harmful effects of this compound is important from the public health standpoint. Ingestion of large amounts of capsaicin has been reported to cause histopathological and biochemical changes, including erosion of gastric mucosa and hepatic necrosis. However, there are contradictory data on the mutagenicity of capsaicin. A recent epidemiological study conducted in Mexico revealed that consumers of chili pepper were at higher risk for gastric cancer than non-consumers. However, it remains unclear whether capsaicin present in hot chili pepper is a major causative factor in the aetiology of gastric cancer in humans. A growing number of recent studies have focused on anticarcinogenic or antimutagenic phytochemicals, particularly those included in human diet. In summary, capsaicin has dual effects on chemically induced carcinogenesis and mutagenesis. Although a minute amount of capsaicin displays few or no deleterious effects, heavy ingestion of the compound has been associated with necrosis, ulceration and even carcinogenesis. Capsaicin is considered to be metabolized by cytochrome P-450-dependent mixed-function oxidases to reactive species. (A7835). An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. See also: Capsicum (part of); Capsicum Oleoresin (active moiety of); Paprika (part of) ... View More ... Capsaicin is identified as the primary pungent principle in Capsicum fruits. Hot chili peppers that belong to the plant genus Capsicum (family Solanaceae) are among the most heavily consumed spices throughout the world. The capsaicin content of green and red peppers ranges from 0.1 to 1\\\\\\%. Capsaicin evokes numerous biological effects and thus has been the target of extensive., investigations since its initial identification in 1919. One of the most recognized physiological properties of capsaicin is its selective effects on the peripheral part of the sensory nervous system, particularly on the primary afferent neurons. The compound is known to deplete the neurotransmitter of painful impulses known as substance P from the sensory nerve terminals, which provides a rationale for its use as a versatile experimental tool for studying pain mechanisms and also for pharmacotherapy to treat some peripheral painful states, such as rheumatoid arthritis, post-herpetic neuralgia, post-mastectomy pain syndrome and diabetic neuropathy. Considering the frequent consumption of capsaicin as a food additive and its current therapeutic application, correct assessment of any harmful effects of this compound is important from the public health standpoint. Ingestion of large amounts of capsaicin has been reported to cause histopathological and biochemical changes, including erosion of gastric mucosa and hepatic necrosis. However, there are contradictory data on the mutagenicity of capsaicin. A recent epidemiological study conducted in Mexico revealed that consumers of chili pepper were at higher risk for gastric cancer than non-consumers. However, it remains unclear whether capsaicin present in hot chili pepper is a major causative factor in the aetiology of gastric cancer in humans. A growing number of recent studies have focused on anticarcinogenic or antimutagenic phytochemicals, particularly those included in human diet. In summary, capsaicin has dual effects on chemically induced carcinogenesis and mutagenesis. Although a minute amount of capsaicin displays few or no deleterious effects, heavy ingestion of the compound has been associated with necrosis, ulceration and even carcinogenesis. Capsaicin is considered to be metabolized by cytochrome P-450-dependent mixed-function oxidases to reactive species. (PMID: 8621114). M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AB - Capsaicin and similar agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic Flavouring ingredient. Pungent principle of various Capsicum subspecies (Solanaceae) D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local D003879 - Dermatologic Agents > D000982 - Antipruritics Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.208 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.207 Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2].

   

BUPROFEZIN

Pesticide5_Buprofezin_C16H23N3OS_(2Z)-2-(tert-Butylimino)-3-(1-methylethyl)-5-phenyl-1,3,5-thiadiazinan-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10057; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10113; ORIGINAL_PRECURSOR_SCAN_NO 10111 ORIGINAL_ACQUISITION_NO 10127; CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10127; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10097; ORIGINAL_PRECURSOR_SCAN_NO 10096 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10129; ORIGINAL_PRECURSOR_SCAN_NO 10128

   

Cetraxate

Cetraxate

C17H23NO4 (305.1627)


A cyclohexanecarboxylate ester that consists of 4-(2-carboxyethyl)phenyl cyclohexanecarboxylate bearing an aminomethyl substituent at the 4-position. C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

   

Convolamine

(8-BROMO-1-NAPHTHYL)METHANOL

C17H23NO4 (305.1627)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids

   

Racanisodamine

(6S)-6-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   
   

Lunacridine

(+/-)-Lunacridine

C17H23NO4 (305.1627)


   

NCIOpen2_008262

17beta-Nitro-5alpha-androstane

C19H31NO2 (305.2355)


   
   

6-Oxolividamine

6-Oxolividamine

C12H23N3O6 (305.1587)


   

4-Oxolividamine

4-Oxolividamine; 3-Deoxy-4-oxoparomamine

C12H23N3O6 (305.1587)


An aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-2,3-dideoxy-alpha-D-erythro-hexopyranosid-4-ulose derivative.

   

anisodamine

[(3S,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


Syndesine is found in animal foods. Syndesine is an intramolecular crosslink of collagen. An intramolecular crosslink of collagen. Syndesine is found in animal foods.

   

Halocins

1,1-diphenyl-4-(piperidin-1-yl)but-2-yn-1-ol

C21H23NO (305.178)


Halocins is produced by Haloferax species Bacteriocins with potential food uses. Production by Haloferax subspecies Bacteriocins with potential food uses

   

N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine

N,N-Dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine

C21H23NO (305.178)


   

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoic acid

C17H23NO4 (305.1627)


   

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidate

C18H27NO3 (305.1991)


   

Amafolone

5-amino-4-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H31NO2 (305.2355)


   

Therafectin

1-[6-[3-(Dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol

C14H27NO6 (305.1838)


   

Aurantiol

Methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoic acid

C18H27NO3 (305.1991)


   

2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol

2-({[1-(1H-imidazol-5-yl)propan-2-yl]imino}(phenyl)methyl)phenol

C19H19N3O (305.1528)


   

Applaud

2-Tert-butylimino-3-isopropyl-5-phenyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazin-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Cetraxate

4-(2-Carboxyethyl)phenyl-trans-4-aminomethylcyclohexane carboxylate hydrochloride

C17H23NO4 (305.1627)


   

Cianopramine

2-[3-(dimethylamino)propyl]-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carbonitrile

C20H23N3 (305.1892)


   

Cyanoimipramine

2-[3-(dimethylamino)propyl]-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbonitrile

C20H23N3 (305.1892)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

Fezolamine

[3-(3,4-diphenyl-1H-pyrazol-1-yl)propyl]dimethylamine

C20H23N3 (305.1892)


   

Indenopyridine

2-ethyl-7-methyl-5-(4-methylphenyl)-1H,2H,3H,4H,4aH,5H,9bH-indeno[1,2-c]pyridine

C22H27N (305.2143)


   

Nonyl acridine

1-nonylacridine

C22H27N (305.2143)


   

di-homo-gamma-linolenate

icosa-8,11,14-trienoic acid

C20H33O2 (305.248)


Di-homo-gamma-linolenate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Di-homo-gamma-linolenate can be found in a number of food items such as shiitake, boysenberry, jute, and cocoa bean, which makes di-homo-gamma-linolenate a potential biomarker for the consumption of these food products.

   

Anisodamine

7(c)micro-hydroxyhyoscyamine;Raceanisodamine; alpha-(Hydroxymethyl)benzeneacetic acid 6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Tropic acid 6-hydroxy-3-tropanyl ester

C17H23NO4 (305.1627)


6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate is a natural product found in Hyoscyamus niger with data available. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Anisodamine has been investigated for the treatment of Intestinal Diseases. 6-Hydroxyhyoscyamine is a natural product found in Duboisia myoporoides, Anisodus tanguticus, and Hyoscyamus albus with data available. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1]. Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].

   

Tuberostemoamide

Tuberostemoamide

C17H23NO4 (305.1627)


   

Knightalbinol

Knightalbinol

C17H23NO4 (305.1627)


   

9-Demethylprotoemetinol

9-Demethylprotoemetinol

C18H27NO3 (305.1991)


   

Acetyldebenzoylalopecurine

2alpha-O-Acetyl-lycopecurine

C18H27NO3 (305.1991)


   

Lycophlegmarine

Lycophlegmarine

C18H27NO3 (305.1991)


   
   

7beta-Hydroxyhyoscyamine

(+)-7b-Hydroxyhyoscyamine

C17H23NO4 (305.1627)


   

N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine

N,N-Dimethyl-alpha-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine

C21H23NO (305.178)


   
   

1-Hexyl-3-(1-naphthoyl)pyrrole

1-Hexyl-3-(1-naphthoyl)pyrrole

C21H23NO (305.178)


   
   

1,4-Epoxy-3-aza-A-homoandrostan-17-ol

1,4-Epoxy-3-aza-A-homoandrostan-17-ol

C19H31NO2 (305.2355)


   

8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate|bonabiline B

8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate|bonabiline B

C18H27NO3 (305.1991)


   

methyl alpha-4-epi-vancosaminopyranosyl(1->4)-beta-digitoxopyranoside

methyl alpha-4-epi-vancosaminopyranosyl(1->4)-beta-digitoxopyranoside

C14H27NO6 (305.1838)


   

Phellibilidine

Phellibilidine

C17H23NO4 (305.1627)


   

Decarbomethoxy naucl echine

Decarbomethoxy naucl echine

C19H19N3O (305.1528)


   

Goshuyuamide I

Goshuyuamide I

C19H19N3O (305.1528)


   

13-hydroxyisopyrodysinoic acid

13-hydroxyisopyrodysinoic acid

C17H23NO4 (305.1627)


   

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

C19H19N3O (305.1528)


   

AKOS030687758

AKOS030687758

C17H23NO4 (305.1627)


   

SCHEMBL5807496

SCHEMBL5807496

C17H23NO4 (305.1627)


   

17-hydroxyimino-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-ol

17-hydroxyimino-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-ol

C19H31NO2 (305.2355)


   

1,2,3,4,4a,5,7,8,14,14a-decahydro-5,14-ethano-indolo[2,3:3,4]pyrido[1,2-g][1,6]naphthyridine|Nitramidin|Nitramidine

1,2,3,4,4a,5,7,8,14,14a-decahydro-5,14-ethano-indolo[2,3:3,4]pyrido[1,2-g][1,6]naphthyridine|Nitramidin|Nitramidine

C20H23N3 (305.1892)


   

obscurumine B

obscurumine B

C18H27NO3 (305.1991)


   

3-Methoxy-4-O-methyljoubertiaminol

3-Methoxy-4-O-methyljoubertiaminol

C18H27NO3 (305.1991)


   
   

Acetyllycoposerramine M

Acetyllycoposerramine M

C18H27NO3 (305.1991)


   

5-acetyllycofoline

5-acetyllycofoline

C18H27NO3 (305.1991)


   

dehydroisofawcettiine

dehydroisofawcettiine

C18H27NO3 (305.1991)


   

isophellibilidine

isophellibilidine

C17H23NO4 (305.1627)


   

stemona-lactam P

stemona-lactam P

C17H23NO4 (305.1627)


   

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

(-)-kunstleramide|(2E,4E)-7-(3,4-dimethoxyphenyl)-N-ethyl-6-(R)-hydroxyhepta-2,4-dienamide

C17H23NO4 (305.1627)


   
   
   

Physochlain|Physochlaine

Physochlain|Physochlaine

C17H23NO4 (305.1627)


   

norcoronatine

norcoronatine

C17H23NO4 (305.1627)


   

Beta-Naucleonine|Naucleonine

Beta-Naucleonine|Naucleonine

C19H19N3O (305.1528)


   

7-Hydroxy-3,6-ditigloyloxytropan

7-Hydroxy-3,6-ditigloyloxytropan

C18H27NO3 (305.1991)


   

O3-Demethylhippeastidine

O3-Demethylhippeastidine

C17H23NO4 (305.1627)


   
   
   
   
   
   
   
   
   

Capsaicin

Capsaicin

C18H27NO3 (305.1991)


Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2].

   

(Z)-Capsaicin

NCGC00017337-18_C18H27NO3_6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)-

C18H27NO3 (305.1991)


   

Convolvamine

Convolvamine

C17H23NO4 (305.1627)


Annotation level-1

   

Dapoxetine

Dapoxetine

C21H23NO (305.178)


C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   
   
   
   

Cyproheptadine (hydroxylated aromatic)

Cyproheptadine (hydroxylated aromatic)

C21H23NO (305.178)


   
   
   

(+)-Samandarine

(+)-Samandarine

C19H31NO2 (305.2355)


   

(7R,E)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-en-3-one

(7R,E)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloct-4-en-3-one

C19H31NO2 (305.2355)


   

(8S,Z)-6-((R,4E,6E)-8-hydroxy-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((R,4E,6E)-8-hydroxy-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H31NO2 (305.2355)


   

(7R,8R,E)-6-((R,3E,5E)-2,6-dimethylocta-3,5-dien-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((R,3E,5E)-2,6-dimethylocta-3,5-dien-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

C19H31NO2 (305.2355)


   

(7R,8R,E)-6-((R,4E,6E)-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((R,4E,6E)-2,5-dimethylocta-4,6-dien-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

C19H31NO2 (305.2355)


   
   
   

Halocins

1,1-diphenyl-4-(piperidin-1-yl)but-2-yn-1-ol

C21H23NO (305.178)


   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


   

(S)-N,N-DIMETHYLPIPERIDINE-3-CARBOXAMIDE

(S)-N,N-DIMETHYLPIPERIDINE-3-CARBOXAMIDE

C20H23N3 (305.1892)


   

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4S)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

Fezolamine

Fezolamine

C20H23N3 (305.1892)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

C19H19N3O (305.1528)


   

4-N-DODECYLOXYBENZAMIDE

4-N-DODECYLOXYBENZAMIDE

C19H31NO2 (305.2355)


   

8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-BUTYLAMINE

8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-BUTYLAMINE

C17H27N3O2 (305.2103)


   

N-BOC-4-PHENYLNIPECOTIC ACID

N-BOC-4-PHENYLNIPECOTIC ACID

C17H23NO4 (305.1627)


   

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

4-(4-Carboxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester

C17H23NO4 (305.1627)


   

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

3-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   
   

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

(S)-N-BOC-4-FLUOROPHENYLGLYCINE

C17H23NO4 (305.1627)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(2-AMINO-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(2-AMINO-PHENYL)-ETHYL]-PYRROLIDINE

C17H27N3O2 (305.2103)


   

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

C17H23NO4 (305.1627)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(P-TOLYL)PYRROLIDINE-3-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

1-BOC-4-(4-METHYLAMINOBENZYL)PIPERAZINE

1-BOC-4-(4-METHYLAMINOBENZYL)PIPERAZINE

C17H27N3O2 (305.2103)


   

Cbz-D-Cyclohexylalanine

Cbz-D-Cyclohexylalanine

C17H23NO4 (305.1627)


   

2-(morpholin-4-ylamino)pyridine-5-boronic acid pinacol ester

2-(morpholin-4-ylamino)pyridine-5-boronic acid pinacol ester

C15H24BN3O3 (305.1911)


   

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

(3S,4R)-1-tert-butoxycarbonyl-3-phenyl-piperidine-4-carboxylic ac id

C17H23NO4 (305.1627)


   

BOC--BENZYL-DL-PRO-OH

BOC--BENZYL-DL-PRO-OH

C17H23NO4 (305.1627)


   

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

C17H23NO4 (305.1627)


   

5-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

5-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

boc-(s)-alpha-benzyl-proline

boc-(s)-alpha-benzyl-proline

C17H23NO4 (305.1627)


   

Cianopramine

Cianopramine

C20H23N3 (305.1892)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist

   

ETHYL N-CBZ-2-PIPERIDINEACETATE

ETHYL N-CBZ-2-PIPERIDINEACETATE

C17H23NO4 (305.1627)


   

n-[3-(triethoxysilyl)propyl]-2-carbomethoxyaziridine

n-[3-(triethoxysilyl)propyl]-2-carbomethoxyaziridine

C13H27NO5Si (305.1658)


   

4-(dihexylamino)benzoic acid

4-(dihexylamino)benzoic acid

C19H31NO2 (305.2355)


   

Orphenadrine hydrochloride

Orphenadrine hydrochloride

C18H24ClNO (305.1546)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AB - Ethers chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

diethyl 1-benzylpyrrolidine-2,5-dicarboxylate

diethyl 1-benzylpyrrolidine-2,5-dicarboxylate

C17H23NO4 (305.1627)


   

4-(2-Methoxyethylaminocarbonyl)benzeneboronic acid pinacol ester

4-(2-Methoxyethylaminocarbonyl)benzeneboronic acid pinacol ester

C16H24BNO4 (305.1798)


   

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

C19H19N3O (305.1528)


   

2-[2-(dimethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate

2-[2-(dimethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate

C18H27NO3 (305.1991)


   

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C16H23N3OS (305.1562)


   

boc-(r)-alpha-benzyl-proline

boc-(r)-alpha-benzyl-proline

C17H23NO4 (305.1627)


   

H-Ala-Ala-Ala-OMe acetate salt

H-Ala-Ala-Ala-OMe acetate salt

C12H23N3O6 (305.1587)


   

4-TERT-BUTOXYCARBONYLAMINO-1-(4-AMINOBENZYL)PIPERIDINE

4-TERT-BUTOXYCARBONYLAMINO-1-(4-AMINOBENZYL)PIPERIDINE

C17H27N3O2 (305.2103)


   

N-Octanoyl-β-D-glucosylamine

N-Octanoyl-β-D-glucosylamine

C14H27NO6 (305.1838)


   

1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-6-phenyl-3-piperidinecarboxylic acid

1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-6-phenyl-3-piperidinecarboxylic acid

C17H23NO4 (305.1627)


   

TERT-BUTYL (4-(PIPERAZINE-1-CARBONYL)PHENYL)CARBAMATE

TERT-BUTYL (4-(PIPERAZINE-1-CARBONYL)PHENYL)CARBAMATE

C16H23N3O3 (305.1739)


   

1-BENZYL 3-ETHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

1-BENZYL 3-ETHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

C17H23NO4 (305.1627)


   

1-BENZYL 4-ETHYL 4-METHYLPIPERIDINE-1,4-DICARBOXYLATE

1-BENZYL 4-ETHYL 4-METHYLPIPERIDINE-1,4-DICARBOXYLATE

C17H23NO4 (305.1627)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

C19H20BNO2 (305.1587)


   

1-Cbz-3-isopropylpiperidine-3-carboxylic Acid

1-Cbz-3-isopropylpiperidine-3-carboxylic Acid

C17H23NO4 (305.1627)


   

Methyl 1-Cbz-3-ethylpiperidine-3-carboxylate

Methyl 1-Cbz-3-ethylpiperidine-3-carboxylate

C17H23NO4 (305.1627)


   

Bifemelane hydrochloride

Bifemelane hydrochloride

C18H24ClNO (305.1546)


   

tert-butyl 3-[4-(dimethylamino)phenyl]piperazine-1-carboxylate

tert-butyl 3-[4-(dimethylamino)phenyl]piperazine-1-carboxylate

C17H27N3O2 (305.2103)


   

Boc-(R)-3-Amino-(6-phenyl)-5-hexenoic acid

Boc-(R)-3-Amino-(6-phenyl)-5-hexenoic acid

C17H23NO4 (305.1627)


   

2-(TETRAHYDRO-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDINE

2-(TETRAHYDRO-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDINE

C16H24BNO4 (305.1798)


   

3-TERT-BUTYL 2-METHYL 4,5-DIHYDRO-1H-BENZO[D]AZEPINE-2,3(2H)-DICARBOXYLATE

3-TERT-BUTYL 2-METHYL 4,5-DIHYDRO-1H-BENZO[D]AZEPINE-2,3(2H)-DICARBOXYLATE

C17H23NO4 (305.1627)


   

4-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

4-PHENYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

H-Arg-Ala-OH acetate salt

H-Arg-Ala-OH acetate salt

C11H23N5O5 (305.1699)


   

2-{4-[3-(dimethylamino)propoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-{4-[3-(dimethylamino)propoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C17H28BNO3 (305.2162)


   

N-Benzyloxycarbonyl-L-proline tert-butyl ester

N-Benzyloxycarbonyl-L-proline tert-butyl ester

C17H23NO4 (305.1627)


   

Benzyl 5-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

Benzyl 5-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate

C17H23NO4 (305.1627)


   

(r)-(+)-n-(tert-butoxycarbonyl)-o-

(r)-(+)-n-(tert-butoxycarbonyl)-o-

C14H31NO4Si (305.2022)


   

ethyl prop-2-enoate,formaldehyde,prop-2-enamide,styrene

ethyl prop-2-enoate,formaldehyde,prop-2-enamide,styrene

C17H23NO4 (305.1627)


   

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

C18H24ClNO (305.1546)


   

1-pentyl-3-(phenylacetyl)indole

1-pentyl-3-(phenylacetyl)indole

C21H23NO (305.178)


   

4-Cyano-4-nonylbiphenyl

4-Cyano-4-nonylbiphenyl

C22H27N (305.2143)


   

(R)-tert-butyl 3-(aminomethyl)-4-benzylpiperazine-1-carboxylate

(R)-tert-butyl 3-(aminomethyl)-4-benzylpiperazine-1-carboxylate

C17H27N3O2 (305.2103)


   

5-dodecyl-2-hydroxybenzaldehyde oxime

5-dodecyl-2-hydroxybenzaldehyde oxime

C19H31NO2 (305.2355)


   

2-Naphthaleneacetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,4-tetrahydro

2-Naphthaleneacetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,4-tetrahydro

C17H23NO4 (305.1627)


   

tert-butyl 4-(3-aminobenzoyl)piperazine-1-carboxylate

tert-butyl 4-(3-aminobenzoyl)piperazine-1-carboxylate

C16H23N3O3 (305.1739)


   

tert-butyl 4-(2-amino-1-phenylethyl)piperazine-1-carboxylate

tert-butyl 4-(2-amino-1-phenylethyl)piperazine-1-carboxylate

C17H27N3O2 (305.2103)


   
   
   

1-phenylmethoxycarbonyl-3-propan-2-ylpiperidine-3-carboxylic acid

1-phenylmethoxycarbonyl-3-propan-2-ylpiperidine-3-carboxylic acid

C17H23NO4 (305.1627)


   

pempidine hydrogen tartrate

pempidine hydrogen tartrate

C14H27NO6 (305.1838)


   

tert-butyl 4-(2-hydroxyethyl)-4-phenylpiperidine-1-carboxylate

tert-butyl 4-(2-hydroxyethyl)-4-phenylpiperidine-1-carboxylate

C18H27NO3 (305.1991)


   
   

Terbinafine Impurity 5

Terbinafine Impurity 5

C22H27N (305.2143)


   

CIS-DIETHYL 1-BENZYLPYRROLIDINE-3,4-DICARBOXYLATE

CIS-DIETHYL 1-BENZYLPYRROLIDINE-3,4-DICARBOXYLATE

C17H23NO4 (305.1627)


   

2,3,4,5-Tetrahydro-2-methyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole

2,3,4,5-Tetrahydro-2-methyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole

C20H23N3 (305.1892)


   

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

C18H24ClNO (305.1546)


   

Boc-(S)-3-Amino-(6-phenyl)-5-hexenoic acid

Boc-(S)-3-Amino-(6-phenyl)-5-hexenoic acid

C17H23NO4 (305.1627)


   

2-(2-Methyl-benzyloxyMethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester

2-(2-Methyl-benzyloxyMethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester

C18H27NO3 (305.1991)


   

R-Dapoxetine

R-Dapoxetine

C21H23NO (305.178)


   

HEXYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

HEXYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

C14H27NO6 (305.1838)


   

Bucumolol

Bucumolol

C17H23NO4 (305.1627)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

3-(2-Methoxyethylaminocarbonyl)benzeneboronic acid pinacol ester

3-(2-Methoxyethylaminocarbonyl)benzeneboronic acid pinacol ester

C16H24BNO4 (305.1798)


   

Ethyl N-Cbz-4-piperidineacetate

Ethyl N-Cbz-4-piperidineacetate

C17H23NO4 (305.1627)


   

1-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

1-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine

C17H25BFNO2 (305.1962)


   

4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)BENZOIC ACID

4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)BENZOIC ACID

C17H23NO4 (305.1627)


   

1-(3-methoxy-4-nitrophenyl)-4-pyrrolidin-1-ylpiperidine

1-(3-methoxy-4-nitrophenyl)-4-pyrrolidin-1-ylpiperidine

C16H23N3O3 (305.1739)


   

(2S,4R)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4R)-4-BENZYL-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

2-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

2-PHENYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C17H23NO4 (305.1627)


   

4-HYDRAZINOCARBONYL-2-PHENYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-HYDRAZINOCARBONYL-2-PHENYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H23N3O3 (305.1739)


   

1-(TERT-BUTOXYCARBONYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

C17H23NO4 (305.1627)


   

tert-butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

tert-butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

C16H23N3O3 (305.1739)


   

Droxypropine

Droxypropine

C18H27NO3 (305.1991)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

Atropine oxide

Atropine oxide

C17H23NO4 (305.1627)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Farnesylthiotriazole

Farnesylthiotriazole

C17H27N3S (305.1926)


   

(2R,3R,11bR)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine-2,9-diol

(2R,3R,11bR)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine-2,9-diol

C18H27NO3 (305.1991)


   

17beta-Nitro-5alpha-androstane

17beta-Nitro-5alpha-androstane

C19H31NO2 (305.2355)


   

3-Methyl-1-(4-methylpiperazin-1-yl)pyrido[1,2-a]benzimidazole-4-carbonitrile

3-Methyl-1-(4-methylpiperazin-1-yl)pyrido[1,2-a]benzimidazole-4-carbonitrile

C18H19N5 (305.164)


   

Zucapsaicin

(Z)-Capsaicin

C18H27NO3 (305.1991)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AB - Capsaicin and similar agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

N-(2S,3R)-3-Amino-4-cyclohexyl-2-hydroxy-butano-N-(4-methylphenyl)hydrazide

N-(2S,3R)-3-Amino-4-cyclohexyl-2-hydroxy-butano-N-(4-methylphenyl)hydrazide

C17H27N3O2 (305.2103)


   

(1R)-2-Methyl-1-(phenylmethyl)propyl[(1S)-1-formylpentyl]carbamate

(1R)-2-Methyl-1-(phenylmethyl)propyl[(1S)-1-formylpentyl]carbamate

C18H27NO3 (305.1991)


   

Axsain

(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide

C18H27NO3 (305.1991)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AB - Capsaicin and similar agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local D003879 - Dermatologic Agents > D000982 - Antipruritics Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2]. Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2].

   

di-homo-gamma-linolenate

icosa-8,11,14-trienoic acid

C20H33O2 (305.248)


Di-homo-gamma-linolenate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Di-homo-gamma-linolenate can be found in a number of food items such as shiitake, boysenberry, jute, and cocoa bean, which makes di-homo-gamma-linolenate a potential biomarker for the consumption of these food products. Di-homo-γ-linolenate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Di-homo-γ-linolenate can be found in a number of food items such as shiitake, boysenberry, jute, and cocoa bean, which makes di-homo-γ-linolenate a potential biomarker for the consumption of these food products.

   
   

10-Methoxy-9-methyl-8-(3-methylbut-2-enoxy)-1,3,4,5-tetrahydro-2,5-benzoxazocin-6-one

10-Methoxy-9-methyl-8-(3-methylbut-2-enoxy)-1,3,4,5-tetrahydro-2,5-benzoxazocin-6-one

C17H23NO4 (305.1627)


   

(8Z,11Z,14Z)-Icosatrienoate

(8Z,11Z,14Z)-Icosatrienoate

C20H33O2- (305.248)


   

(5Z,11Z,14Z)-icosatrienoate

(5Z,11Z,14Z)-icosatrienoate

C20H33O2- (305.248)


An icosatrienoate that is the conjugate base of (5Z,11Z,14Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(11Z,14Z,17Z)-icosatrienoate

(11Z,14Z,17Z)-icosatrienoate

C20H33O2- (305.248)


A polyunsaturated fatty acid anion that is the conjugate base of (11Z,14Z,17Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

di-homo-gamma-linolenate

di-homo-gamma-linolenate

C20H33O2- (305.248)


   

Disipal

Disipal

C18H24ClNO (305.1546)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

Alnert

Alnert

C18H24ClNO (305.1546)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

N-decyl-N-(2-pyridinyl)oxamide

N-decyl-N-(2-pyridinyl)oxamide

C17H27N3O2 (305.2103)


   

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

C16H23N3OS (305.1562)


   

(5Z,8Z,11Z)-Icosatrienoate

(5Z,8Z,11Z)-Icosatrienoate

C20H33O2- (305.248)


A polyunsaturated fatty acid anion that is the conjugate base of (5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(3S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate

(3S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate

C17H23NO4 (305.1627)


   

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

C16H23N3OS (305.1562)


   

Hexadecane-1-sulfonate

Hexadecane-1-sulfonate

C16H33O3S- (305.215)


   

6-Hydroxy-1-(3-hydroxypropyl)-4-methyl-2-oxo-5-(1-piperidinylmethyl)-3-pyridinecarbonitrile

6-Hydroxy-1-(3-hydroxypropyl)-4-methyl-2-oxo-5-(1-piperidinylmethyl)-3-pyridinecarbonitrile

C16H23N3O3 (305.1739)


   

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

C16H23N3OS (305.1562)


   

3,4-dimethoxybenzoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

3,4-dimethoxybenzoic acid [(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H23NO4 (305.1627)


   

1-(1-Benzylpiperidin-4-yl)-3-tert-butylthiourea

1-(1-Benzylpiperidin-4-yl)-3-tert-butylthiourea

C17H27N3S (305.1926)


   

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)pyrrolidine-2,4-dione

(3Z)-3-[(2E,4E,6E)-1-hydroxydodeca-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)pyrrolidine-2,4-dione

C17H23NO4 (305.1627)


   
   
   
   
   
   
   

1-[(5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol

1-[(5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol

C14H27NO6 (305.1838)


   

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-methyl-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-methyl-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C16H23N3O3 (305.1739)


   

(1S,5R)-6-(cyclopropylmethyl)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-6-(cyclopropylmethyl)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane

C20H23N3 (305.1892)


   

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-methyl-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-methyl-6-oxo-N-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C16H23N3O3 (305.1739)


   

(1R,5S)-6-(cyclopropylmethyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

(1R,5S)-6-(cyclopropylmethyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane

C20H23N3 (305.1892)


   

(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-6-(pyridin-2-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane

(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-6-(pyridin-2-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane

C20H23N3 (305.1892)


   

(1S,5R)-7-[4-[(E)-prop-1-enyl]phenyl]-3-(pyridin-2-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-7-[4-[(E)-prop-1-enyl]phenyl]-3-(pyridin-2-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane

C20H23N3 (305.1892)


   
   
   
   
   
   
   

(1R)-1-[(3aR,5S,6S,6aS)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol

(1R)-1-[(3aR,5S,6S,6aS)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol

C14H27NO6 (305.1838)


   

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(8-Methyl-8-azabicyclo[3.2.1]oct-3-YL) 3,4-dimethoxybenzoate

(8-Methyl-8-azabicyclo[3.2.1]oct-3-YL) 3,4-dimethoxybenzoate

C17H23NO4 (305.1627)


   
   

N-(2-Acetoxy-2-methylpropionyl)-N-butylbenzamide

N-(2-Acetoxy-2-methylpropionyl)-N-butylbenzamide

C17H23NO4 (305.1627)


   

2,8-Dimethyl-5-(2-(4-pyridyl)ethyl)-1,2,3,4-tetrahydro-gamma-carboline

2,8-Dimethyl-5-(2-(4-pyridyl)ethyl)-1,2,3,4-tetrahydro-gamma-carboline

C20H23N3 (305.1892)


   

atropine oxyde

atropine oxyde

C17H23NO4 (305.1627)


   

cetraxate zwitterion

cetraxate zwitterion

C17H23NO4 (305.1627)


Zwitterionic form of cetraxate arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

icosatrienoate

icosatrienoate

C20H33O2 (305.248)


An unsaturated fatty acid anion that is the conjugate base of icosatrienoic acid arising from deprotonation of the carboxy group. Major species at pH 7.3.

   

all-cis-icosa-8,11,14-trienoate

all-cis-icosa-8,11,14-trienoate

C20H33O2 (305.248)


An unsaturated fatty acid anion that is the conjugate base of all-cis-icosa-8,11,14-trienoic acid arising from deprotonation of the carboxy group.

   

pyranonigrin J

pyranonigrin J

C17H23NO4 (305.1627)


A member of the class of pyrrolidin-2-ones with formula C17H23NO4, originally isolated from Aspergillus niger.

   
   
   

6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

C17H23NO4 (305.1627)


   

(1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1s,3r,5s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1s,2s,4r,8s,10s,11r,13r,15s)-11-hydroxy-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-8-yl acetate

(1s,2s,4r,8s,10s,11r,13r,15s)-11-hydroxy-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-8-yl acetate

C18H27NO3 (305.1991)


   

15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H27NO3 (305.1991)


   

n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO3 (305.1991)


   

(1s,3r,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1r,3s,4s,5s,6r)-3-hydroxy-4-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

(1r,3s,4s,5s,6r)-3-hydroxy-4-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

(8s,9as,13as)-8-hydroxy-12-methoxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[3,3a-e]azonin-13-one

(8s,9as,13as)-8-hydroxy-12-methoxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[3,3a-e]azonin-13-one

C18H27NO3 (305.1991)


   

(2s,3r,6s)-6-[(1e,3e,5e)-deca-1,3,5-trien-1-yl]-1,2-dimethylpiperidin-3-yl acetate

(2s,3r,6s)-6-[(1e,3e,5e)-deca-1,3,5-trien-1-yl]-1,2-dimethylpiperidin-3-yl acetate

C19H31NO2 (305.2355)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate

C18H27NO3 (305.1991)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate

C17H23NO4 (305.1627)


   

8-hydroxy-12-methoxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[3,3a-e]azonin-13-one

8-hydroxy-12-methoxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[3,3a-e]azonin-13-one

C18H27NO3 (305.1991)


   

(1s,12s,14s)-14-hydroxy-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-ium-4-olate

(1s,12s,14s)-14-hydroxy-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-ium-4-olate

C17H23NO4 (305.1627)


   

(6e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

(6e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO3 (305.1991)


   

(1r,4r)-4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-ol

(1r,4r)-4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-ol

C18H27NO3 (305.1991)


   

6-(7-hydroxy-3-methylocta-2,5-dien-1-yl)-3-methyl-5-propylpyridine-2,4-diol

6-(7-hydroxy-3-methylocta-2,5-dien-1-yl)-3-methyl-5-propylpyridine-2,4-diol

C18H27NO3 (305.1991)


   

(1'r,2s,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1'r,2s,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoate

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

(1r,2s,4as,8as)-2-hydroxy-n-(3-methylbutyl)-2-propyl-4a,5,8,8a-tetrahydro-1h-naphthalene-1-carboximidic acid

(1r,2s,4as,8as)-2-hydroxy-n-(3-methylbutyl)-2-propyl-4a,5,8,8a-tetrahydro-1h-naphthalene-1-carboximidic acid

C19H31NO2 (305.2355)


   

(1s,6s,16s)-6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

(1s,6s,16s)-6-(hydroxymethyl)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁶]heptadeca-2,13-dien-4-one

C17H23NO4 (305.1627)


   

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10-pentaene

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10-pentaene

C20H23N3 (305.1892)


   

11-hydroxy-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-8-yl acetate

11-hydroxy-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-8-yl acetate

C18H27NO3 (305.1991)


   

(6e)-7-{[(2s)-1-hydroxy-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}hept-6-enoic acid

(6e)-7-{[(2s)-1-hydroxy-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}hept-6-enoic acid

C17H23NO4 (305.1627)


   

(1s,3s,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

(1s,3s,5s,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2r)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-(4-hydroxyphenyl)propanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-(4-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

2,6-dimethyl-19-oxa-17-azapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁶,¹⁰]nonadecan-8-ol

2,6-dimethyl-19-oxa-17-azapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁶,¹⁰]nonadecan-8-ol

C19H31NO2 (305.2355)


   

(1's,2r,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1's,2r,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

{9a-hydroxy-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h-cyclohexa[f]indol-1-yl}acetic acid

{9a-hydroxy-4,4,7-trimethyl-2-oxo-4ah,5h,6h,8ah,9h-cyclohexa[f]indol-1-yl}acetic acid

C17H23NO4 (305.1627)


   

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

C19H19N3O (305.1528)


   

(s)-lunacridine

(s)-lunacridine

C17H23NO4 (305.1627)


   

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-methylcyclopropane-1-carboxylic acid

(1s,2s)-1-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-2-methylcyclopropane-1-carboxylic acid

C17H23NO4 (305.1627)


   

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(2-hydroxyphenyl)propanoate

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-(2-hydroxyphenyl)propanoate

C17H23NO4 (305.1627)


   

3-ethyl-2-(2-hydroxyethyl)-10-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-9-ol

3-ethyl-2-(2-hydroxyethyl)-10-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-9-ol

C18H27NO3 (305.1991)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

C17H23NO4 (305.1627)


   

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (1s,4r,5r)-4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (1s,4r,5r)-4-hydroxy-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate

C18H27NO3 (305.1991)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-methoxyphenyl)acetate

C17H23NO4 (305.1627)


   

(1s,2r,3s,4s,6r)-3-methyl-4-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

(1s,2r,3s,4s,6r)-3-methyl-4-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

C17H23NO4 (305.1627)


   

(2r,3r,11bs)-3-ethyl-2-(2-hydroxyethyl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

(2r,3r,11bs)-3-ethyl-2-(2-hydroxyethyl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

C18H27NO3 (305.1991)


   

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-ol

4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-ol

C18H27NO3 (305.1991)


   

(1's,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1's,2'r,3's,6'r)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

3-ethyl-2-(2-hydroxyethyl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

3-ethyl-2-(2-hydroxyethyl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

C18H27NO3 (305.1991)


   

2-hydroxy-n-(3-methylbutyl)-2-propyl-4a,5,8,8a-tetrahydro-1h-naphthalene-1-carboximidic acid

2-hydroxy-n-(3-methylbutyl)-2-propyl-4a,5,8,8a-tetrahydro-1h-naphthalene-1-carboximidic acid

C19H31NO2 (305.2355)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(1s,2r,3s,4s,6r)-3-methyl-4-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

(1s,2r,3s,4s,6r)-3-methyl-4-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]-5-oxa-10-azatricyclo[8.3.0.0²,⁶]tridecan-11-one

C17H23NO4 (305.1627)


   

2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindol-1-one

2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindol-1-one

C17H23NO4 (305.1627)


   

3-hydroxy-4-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

3-hydroxy-4-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

(6z)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

(6z)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO3 (305.1991)


   

10-methoxy-9-methyl-8-[(3-methylbut-2-en-1-yl)oxy]-3,4-dihydro-1h-2,5-benzoxazocin-6-ol

10-methoxy-9-methyl-8-[(3-methylbut-2-en-1-yl)oxy]-3,4-dihydro-1h-2,5-benzoxazocin-6-ol

C17H23NO4 (305.1627)


   

(1'r,2r,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

(1'r,2r,2's,3'r,6's)-3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(1s,3r,4s,5r,6r)-3-hydroxy-4-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

(1s,3r,4s,5r,6r)-3-hydroxy-4-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl acetate

C17H23NO4 (305.1627)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2s)-3-hydroxy-2-phenylpropanoate

C17H23NO4 (305.1627)


   

(2r,3r,11bs)-3-ethyl-2-(2-hydroxyethyl)-10-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-9-ol

(2r,3r,11bs)-3-ethyl-2-(2-hydroxyethyl)-10-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-9-ol

C18H27NO3 (305.1991)


   

(6r,9r,9as)-9-hydroxy-6-(2-hydroxypropan-2-yl)-9-methyl-6h,7h,8h,9ah,10h-pyrido[1,2-a]indole-2-carboxylic acid

(6r,9r,9as)-9-hydroxy-6-(2-hydroxypropan-2-yl)-9-methyl-6h,7h,8h,9ah,10h-pyrido[1,2-a]indole-2-carboxylic acid

C17H23NO4 (305.1627)


   

(1r,2r,10s,11r,13s,15s)-15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,15s)-15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H27NO3 (305.1991)


   

6-[(2e,5e,7s)-7-hydroxy-3-methylocta-2,5-dien-1-yl]-3-methyl-5-propylpyridine-2,4-diol

6-[(2e,5e,7s)-7-hydroxy-3-methylocta-2,5-dien-1-yl]-3-methyl-5-propylpyridine-2,4-diol

C18H27NO3 (305.1991)


   

1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-2-methylcyclopropane-1-carboxylic acid

1-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-2-methylcyclopropane-1-carboxylic acid

C17H23NO4 (305.1627)


   

3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

3'-ethyl-4-methyl-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecane]-5,11'-dione

C17H23NO4 (305.1627)


   

(3z)-1-hydroxy-3-[(2e,4e,6e)-1-hydroxytrideca-2,4,6-trien-1-ylidene]pyrrolidine-2,4-dione

(3z)-1-hydroxy-3-[(2e,4e,6e)-1-hydroxytrideca-2,4,6-trien-1-ylidene]pyrrolidine-2,4-dione

C17H23NO4 (305.1627)